Middle East Healthcare Company

SASE:4009 Rapporto sulle azioni

Cap. di mercato: ر.س7.8b

Middle East Healthcare Crescita futura

Future criteri di controllo 3/6

Middle East Healthcare prevede che gli utili e i ricavi cresceranno rispettivamente di 17.9% e 9.6% all'anno. Si prevede che l'EPS crescerà di 17.9% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 17.7% in 3 anni.

Informazioni chiave

17.9%

Tasso di crescita degli utili

17.9%

Tasso di crescita dell'EPS

Healthcare crescita degli utili14.8%
Tasso di crescita dei ricavi9.6%
Rendimento futuro del capitale proprio17.7%
Copertura analitica

Low

Ultimo aggiornamento05 Feb 2025

Aggiornamenti recenti sulla crescita futura

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Dec 16
With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Sep 24
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

Jul 18
Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

May 30
There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Apr 29
If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

Apr 02
Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Feb 11
There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Feb 08
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Jan 18
Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Dec 28
Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Sep 26
Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Jun 28
Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Mar 30
Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Sep 20
Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Jun 14
Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Apr 18
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Aug 10
Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

Mar 29
Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Mar 03
An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 10
Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

Jan 23
Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Jan 05
If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Dec 18
Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Nov 30
Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Previsioni di crescita degli utili e dei ricavi

SASE:4009 - Stime future degli analisti e dati finanziari passati (SAR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20274,0114105256922
12/31/20263,6343463834693
12/31/20253,2503032634703
12/31/20242,9212392936522
9/30/20242,854211203665N/A
6/30/20242,793203-23196N/A
3/31/20242,70418269270N/A
12/31/20232,653180-41191N/A
9/30/20232,55117723282N/A
6/30/20232,39313563346N/A
3/31/20232,276105-95172N/A
12/31/20222,15275-17476N/A
9/30/20222,03324-2929N/A
6/30/20222,01927-3091N/A
3/31/20221,96826-259114N/A
12/31/20211,87317-34177N/A
9/30/20211,82345-434-37N/A
6/30/20211,81666-580-160N/A
3/31/20211,73373-501-166N/A
12/31/20201,75182-524-229N/A
9/30/20201,708110-507-182N/A
6/30/20201,603108-348-23N/A
3/31/20201,583104-440-38N/A
12/31/20191,49798-37399N/A
9/30/20191,40191-351133N/A
6/30/20191,35378-335180N/A
3/31/20191,346100-289164N/A
12/31/20181,391172-197159N/A
9/30/20181,445224-39317N/A
6/30/20181,459269N/A204N/A
3/31/20181,464297N/A135N/A
12/31/20171,462319N/A347N/A
9/30/20171,503322N/A370N/A
6/30/20171,529356N/A256N/A
3/31/20171,588368N/A453N/A
12/31/20161,616363N/A253N/A
9/30/20161,629380N/A72N/A
6/30/20161,602371N/A313N/A
3/31/20161,564389N/A303N/A
12/31/20151,535390N/A194N/A
9/30/20151,485373N/A434N/A
6/30/20151,456356N/A383N/A
3/31/20151,431357N/A253N/A
12/31/20141,399332N/A349N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 4009 ( 17.9% all'anno) è superiore al tasso di risparmio ( 14.7% ).

Guadagni vs Mercato: Si prevede che gli utili di 4009 ( 17.9% all'anno) cresceranno più rapidamente del mercato SA ( 5.9% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 4009 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 4009 ( 9.6% all'anno) crescerà più rapidamente del mercato SA ( -0.5% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 4009 ( 9.6% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 4009 sarà basso tra 3 anni ( 17.7 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2025/02/06 14:02
Prezzo dell'azione a fine giornata2025/02/06 00:00
Guadagni2024/09/30
Guadagni annuali2023/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Middle East Healthcare Company è coperta da 9 analisti. 3 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Jassim Al-JubranAljazira Capital Company
Madhu AppissaAl Rajhi Capital
Christine KalindjianArqaam Capital Research Offshore S.A.L.